Cannabinoid Analgesia as a Potential New Therapeutic Option in the Treatment of Chronic Pain

  title={Cannabinoid Analgesia as a Potential New Therapeutic Option in the Treatment of Chronic Pain},
  author={Tammy L. Burns and Joseph R Ineck},
  journal={Annals of Pharmacotherapy},
  pages={251 - 260}
  • T. Burns, J. Ineck
  • Published 1 February 2006
  • Medicine, Biology
  • Annals of Pharmacotherapy
Objective: To review the literature concerning the physiology of the endocannabinoid system, current drug development of cannabinoid agonists, and current clinical research on the use of cannabinoid agonists for analgesia. Data Sources: Articles were identified through a search of MEDLINE (1966–August 2005) using the key words cannabis, cannabinoid, cannabi*, cannabidiol, nabilone, THC, pain, and analgesia. No search limits were included. Additional references were located through review of the… 

Tables from this paper

The endocannabinoid system and pain.
The roles of anandamide and 2-arachidonoylglycerol, released under physiological conditions, in modulating nociceptive responding at different levels of the neuraxis will be emphasized in this review.
The use of cannabinoids for sleep: A critical review on clinical trials.
A critical review of clinical studies examining the effects of cannabinoids on subjective and objective measures of sleep found many of the studies suggested that cannabinoids could improve sleep quality, decrease sleep disturbances, and decrease sleep onset latency.
Cannabinoids and Pain Relief – M.j.atha Cannabinoids and Pain Relief a Literature Review Matthew J Atha – Independent Drug Monitoring Unit
Pain relief (analgesia) or decreased pain sensitivity (antinociception) are among the most commonly-cited therapeutic effects of smoking cannabis. Although cannabis products have been used for
The Role of the Endogenous Cannabinoid System in Peripheral Analgesia
The main goal of this review is to explain the different interactions regarding the cannabinoid system with other cellular components of its environment, its involvement in the modulation of pain at the peripheral level and, more precisely, in different layers of the skin.
Cannabinoid Receptors and Their Relationship With Chronic Pain: A Narrative Review
This review aims to analyse the role of the cannabinoid system in chronic inflammatory pain and shows that it can be an adjunctive approach towards controlling these symptoms.
Functional role of cannabinoid receptors in urinary bladder
The ongoing search for cannabinoid-based therapeutic strategies devoid of psychotropic effects can be complemented with local delivery into bladder by the intravesical route and a greater understanding of the role of the peripheral CB1 and CB2 receptor system in lower urinary tract is necessary to allow the development of new treatment for pelvic disorders.
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
There was moderate- quality evidence to support the use of cannabinoids for the treatment of chronic pain and spasticity and low-quality evidence suggesting that cannabinoids were associated with improvements in nausea and vomiting due to chemotherapy, weight gain in HIV infection, sleep disorders, and Tourette syndrome.
The Endocannabinoid System, Cannabinoids, and Pain
This review will provide the reader with the foundational basic and clinical science linking the endocannabinoid system and the phytocannabinoids with their potentially therapeutic role in the management of chronic pain.
Systematic review and meta-analysis of cannabis treatment for chronic pain.
Systematic review and meta-analysis of double-blind randomized controlled trials that compared any cannabis preparation to placebo among subjects with chronic pain suggests that cannabis treatment is moderately efficacious for treatment of chronic pain, but beneficial effects may be partially (or completely) offset by potentially serious harms.
Antinociceptive and Abuse Potential Effects of Cannabinoid/Opioid Combinations in a Chronic Pain Model in Rats
Combining CP55940 with morphine, but not tramadol, shows a better antinociceptive profile with no additional risk of abuse liability, which represents a potential pain management approach.


Cannabinoid analgesia.
Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review
Cannabinoids are no more effective than codeine in controlling pain and have depressant effects on the central nervous system that limit their use, and in acute postoperative pain they should not be used.
Pain relief with oral cannabinoids in familial Mediterranean fever
This is the first United Kingdom report of the controlled use of a standardised pharmaceutical preparation of cannabinoids in capsular form and a highly significant reduction in additional analgesic requirements was achieved.
Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.
In this preliminary study, CT-3 was effective in reducing chronic neuropathic pain compared with placebo and no major adverse effects were observed.
An analgesia circuit activated by cannabinoids
It is shown that a brainstem circuit that contributes to the pain-suppressing effects of morphine is also required for the analgesic effects of cannabinoids, and that cannabinoids are indeed centrally acting analgesics with a new mechanism of action.
Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 ‘N of 1’ studies
A total of 34 ‘N of 1’ studies were undertaken using this novel therapy for patients with chronic, mainly neuropathic, pain and associated symptoms to explore efficacy, tolerability, safety and dosages of CBME.